{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:31:23Z","timestamp":1793745083571,"version":"4.6.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Glomerular disease is an important complication in patients undergoing hematopoietic stem cell transplantation (HSCT), impacting approximately 1%\u20132% of all HSCT recipients and equating to 700\u20131400 cases per year worldwide. Development of kidney disease in HSCT recipients is often multifactorial and a kidney biopsy is required to identify the underlying disease etiology and pathology. While glomerular disease is an important toxicity following HSCT, there are few kidney biopsy studies examining this complication, with the majority being limited to small series and case reports. A range of glomerular diseases may occur in association with HSCT. The study by Yap et al. defines this disease spectrum, which includes (in descending order) thrombotic microangiopathy (38.7%), membranous nephropathy (25.8%), mesangial proliferative glomerulonephritis (12.9%), minimal change disease (9.7%), focal segmental glomerulosclerosis (9.7%) and membranoproliferative glomerulonephritis (3.2%). In this editorial, we summarize the study and prior studies looking at glomerular diseases associated with HSCT.<\/jats:p>","DOI":"10.1093\/ckj\/sfad023","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T01:15:10Z","timestamp":1675732510000},"page":"896-900","source":"Crossref","is-referenced-by-count":9,"title":["Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms"],"prefix":"10.1093","volume":"16","author":[{"given":"Tiffany N","family":"Caza","sequence":"first","affiliation":[{"name":"Arkana Laboratories , 10810 Executive Center Drive #100, Little Rock, AR , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1578-0524","authenticated-orcid":false,"given":"Kenar D","family":"Jhaveri","sequence":"additional","affiliation":[{"name":"Division of Kidney Diseases and Hypertension at Hofstra\/Northwell and the Glomerular Center at Northwell Health , Lake Success, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"2023053100305717200_bib1","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/S2352-3026(15)00028-9","article-title":"One million haemopoietic stem-cell transplants: a retrospective observational study","volume":"2","author":"Gratwohl","year":"2015","journal-title":"Lancet Haematol"},{"key":"2023053100305717200_bib2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1523-1755.2005.00078.x","article-title":"Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors","volume":"67","author":"Hingorani","year":"2005","journal-title":"Kidney Int"},{"key":"2023053100305717200_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfac264","article-title":"Clinico-pathological correlations and outcomes of de novo glomerular","author":"Yap","year":"2022","journal-title":"Clin Kidney J"},{"key":"2023053100305717200_bib4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.2215\/CJN.01700407","article-title":"Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients and review of the literature","volume":"2","author":"Chang","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023053100305717200_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/ejh.12149","article-title":"Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant","volume":"91","author":"Fraile","year":"2013","journal-title":"Eur J Haematol"},{"key":"2023053100305717200_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/asheducation-2008.1.134","article-title":"Recognizing and managing chronic graft-versus-host disease","volume":"2008","author":"Lee","year":"2008","journal-title":"Hematology"},{"key":"2023053100305717200_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2018.06.013","article-title":"Emerging concepts in hematopoietic stem cell transplantation-associated renal thrombotic microangiopathy and prospects for new treatments","volume":"72","author":"Wanchoo","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2023053100305717200_bib8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4070\/kcj.2013.43.12.804","article-title":"Incidence and risk factors for early-onset hypertension after allogeneic hematopoietic stem cell transplantation in children","volume":"43","author":"Kwon","year":"2013","journal-title":"Korean Circ J"},{"key":"2023053100305717200_bib9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbmt.2009.11.018","article-title":"Hypertension in long-term survivors of pediatric hematopoietic cell transplantation","volume":"16","author":"Hoffmeister","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"2023053100305717200_bib10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1055\/s-2005-925475","article-title":"Thrombotic microangiopathy in transplantation and malignancy","volume":"31","author":"Qu","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"2023053100305717200_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1083-8791(03)00243-X","article-title":"Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation","volume":"9","author":"El-Seisi","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"2023053100305717200_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000046273","article-title":"Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature","volume":"21","author":"Lin","year":"2001","journal-title":"Am J Nephrol"},{"key":"2023053100305717200_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.humpath.2015.12.005","article-title":"Clinicopathological analysis of allogeneic hematopoietic stem cell transplantation-related membranous glomerulonephritis","volume":"50","author":"Hiramatsu","year":"2016","journal-title":"Hum Pathol"},{"key":"2023053100305717200_bib14","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1681\/ASN.2021111488","article-title":"Hematopoietic stem cell transplant-membranous nephropathy is associated with protocadherin FAT1","volume":"33","author":"Sethi","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"2023053100305717200_bib15","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.ekir.2021.04.033","article-title":"NELL1-associated membranous glomerulopathy after hematopoietic stem cell transplantation","volume":"6","author":"Kudose","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2023053100305717200_bib16","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/sj.ki.5000341","article-title":"Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature","volume":"69","author":"Audard","year":"2006","journal-title":"Kidney Int"},{"key":"2023053100305717200_bib17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/bmt.2010.222","article-title":"Focal segmental glomerulosclerosis: a very unusual complication of allogeneic hematopoietic cell transplantation (HCT)","volume":"46","author":"Lopes","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"2023053100305717200_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2169\/internalmedicine.43.512","article-title":"Minimal change nephrotic syndrome after allogenic hematopoietic stem cell transplantation","volume":"43","author":"Sato","year":"2004","journal-title":"Intern Med"},{"key":"2023053100305717200_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1752-1947-1-121","article-title":"Minimal change nephrotic syndrome after stem cell transplantation: a case report and literature review","volume":"1","author":"Silva","year":"2007","journal-title":"J Med Case Rep"},{"key":"2023053100305717200_bib20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MD.0000000000000206","article-title":"Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: a retrospective study of 18 cases","volume":"93","author":"Kofman","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"2023053100305717200_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.ackd.2013.08.003","article-title":"Glomerular diseases associated with cancer, chemotherapy, and hematopoietic stem cell transplantation","volume":"21","author":"Jhaveri","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"2023053100305717200_bib22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s10157-010-0337-5","article-title":"Membranoproliferative glomerulonephritis following allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Kim","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"2023053100305717200_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/j.ajkd.2006.03.085","article-title":"Mesangial proliferative glomerulonephritis after autologous stem cell transplantation","volume":"48","author":"Forslund","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2023053100305717200_bib24","first-page":"1147","article-title":"A histologic study of the extracellular matrix during the development of glomerulosclerosis in murine chronic graft-versus-host disease","volume":"140","author":"Bergijk","year":"1992","journal-title":"Am J Pathol"},{"key":"2023053100305717200_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2141.2005.05728.x","article-title":"Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation","volume":"131","author":"Srinivasan","year":"2005","journal-title":"Br J Haematol"},{"key":"2023053100305717200_bib26","doi-asserted-by":"crossref","first-page":"608","DOI":"10.5500\/wjt.v6.i4.608","article-title":"Biology of chronic graft-vs-host disease: immune mechanisms and progress in biomarker discovery","volume":"6","author":"Presland","year":"2016","journal-title":"World J Transplant"},{"key":"2023053100305717200_bib27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.bmt.1704151","article-title":"Nephrotic syndrome following allogeneic stem cell transplantation associated with increased production of TNF-alpha and interferon-gamma by donor T cells","volume":"32","author":"Seconi","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"2023053100305717200_bib28","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.4049\/jimmunol.161.10.5321","article-title":"The nephritogenic T cell response in murine chronic graft-versus-host disease","volume":"161","author":"Meyers","year":"1998","journal-title":"J Immunol"},{"key":"2023053100305717200_bib29","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1182\/blood-2010-10-313684","article-title":"Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells","volume":"118","author":"Shin","year":"2011","journal-title":"Blood"},{"key":"2023053100305717200_bib30","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.leukres.2012.04.022","article-title":"Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus\/sirolimus-based GVHD prophylaxis","volume":"36","author":"Nakamura","year":"2012","journal-title":"Leuk Res"},{"key":"2023053100305717200_bib31","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.4049\/jimmunol.135.6.3850","article-title":"Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA","volume":"135","author":"Portanova","year":"1985","journal-title":"J Immunol"},{"key":"2023053100305717200_bib32","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2015-12-688895","article-title":"Circulating T follicular helper cells with increased function during chronic graft-versus-host disease","volume":"127","author":"Forcade","year":"2016","journal-title":"Blood"},{"key":"2023053100305717200_bib33","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1182\/blood-2007-08-106286","article-title":"Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group","volume":"111","author":"Fujii","year":"2008","journal-title":"Blood"},{"key":"2023053100305717200_bib34","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2007-11-125542","article-title":"Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells","volume":"112","author":"Gatza","year":"2008","journal-title":"Blood"},{"key":"2023053100305717200_bib35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.2005.05616.x","article-title":"Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease","volume":"130","author":"Couriel","year":"2005","journal-title":"Br J Haematol"},{"key":"2023053100305717200_bib36","doi-asserted-by":"crossref","first-page":"995149","DOI":"10.3389\/fimmu.2022.995149","article-title":"BAFF blockade attenuates acute graft-versus-host disease directly via the dual regulation of T- and B-cell homeostasis","volume":"13","author":"Jeon","year":"2022","journal-title":"Front Immunol"},{"key":"2023053100305717200_bib37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2006-01-0233","article-title":"Rituximab for steroid-refractory chronic graft-versus-host disease","volume":"108","author":"Cutler","year":"2006","journal-title":"Blood"},{"key":"2023053100305717200_bib38","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.2021011216","article-title":"Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects","volume":"138","author":"Khuat","year":"2021","journal-title":"Blood"},{"key":"2023053100305717200_bib39","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"key":"2023053100305717200_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199907013410103","article-title":"Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry","volume":"341","author":"Soci\u00e9","year":"1999","journal-title":"N Engl J Med"},{"key":"2023053100305717200_bib41","doi-asserted-by":"crossref","first-page":"325.e1","DOI":"10.1016\/j.jtct.2022.03.014","article-title":"Long-term survival after hematopoietic cell transplant for sickle cell disease compared to the United States population","volume":"28","author":"St Martin","year":"2022","journal-title":"Transplant Cell Ther"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfad023\/50093933\/sfad023.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/16\/6\/896\/50462161\/sfad023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/16\/6\/896\/50462161\/sfad023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T04:29:22Z","timestamp":1685507362000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/16\/6\/896\/7028789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,2,6]]},"published-print":{"date-parts":[[2023,5,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfad023","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6]]},"published":{"date-parts":[[2023,2,6]]}}}